|
India News Releases
|
(India.CityRegions.Com, May 14, 2016 ) The report provides comprehensive information on the therapeutics under development for Pulmonary Fibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pulmonary Fibrosis and features dormant and discontinued projects.
Publisher's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Other Key Points in Report:
- The report provides a snapshot of the global therapeutic landscape of Pulmonary Fibrosis - The report reviews pipeline therapeutics for Pulmonary Fibrosis by companies and universities/research institutes based on information derived from company and industry-specific sources - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved Pulmonary Fibrosis therapeutics and enlists all their major and minor projects - The report assesses Pulmonary Fibrosis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report summarizes all the dormant and discontinued pipeline projects - The report reviews latest news related to pipeline therapeutics for Pulmonary Fibrosis
Inquire before Purchasing Report @ http://www.reportsweb.com/inquiry&RW0001236047/buying
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Pulmonary Fibrosis - Identify potential new clients or partners in the target demographic - Develop strategic initiatives by understanding the focus areas of leading companies - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Pulmonary Fibrosis pipeline depth and focus of Indication therapeutics
Ask for Sample Report @ http://www.reportsweb.com/inquiry&RW0001236047/sample
Table of Content: An Overview
Introduction 10 Publisher Report Coverage 10 Pulmonary Fibrosis Overview 11 Therapeutics Development 12 Pipeline Products for Pulmonary Fibrosis - Overview 12 Pipeline Products for Pulmonary Fibrosis - Comparative Analysis 13 Pulmonary Fibrosis - Therapeutics under Development by Companies 14 Pulmonary Fibrosis - Therapeutics under Investigation by Universities/Institutes 20 Pulmonary Fibrosis - Pipeline Products Glance 21 Clinical Stage Products 21 Early Stage Products 22 Pulmonary Fibrosis - Products under Development by Companies 23 Pulmonary Fibrosis - Products under Investigation by Universities/Institutes 30 Pulmonary Fibrosis - Companies Involved in Therapeutics Development 31 AdAlta Pty Ltd. 31 Advinus Therapeutics Ltd. 32 Aeolus Pharmaceuticals, Inc. 33 Afferent Pharmaceuticals, Inc. 34 AnaMar AB 35 Angion Biomedica Corp. 36 Antitope Limited 37 aTyr Pharma, Inc. 38
Ask for Discount on Report @ http://www.reportsweb.com/inquiry&RW0001236047/discount
Biogen, Inc. 39 Bioneer Corporation 40 BiOrion Technologies B.V. 41 Bristol-Myers Squibb Company 42 Carolus Therapeutics, Inc. 43 Celgene Corporation 44 Chong Kun Dang Pharmaceutical Corp. 45 Clanotech AB 46 Compugen Ltd. 47 Cynata Therapeutics Limited 48 Diffusion Pharmaceuticals Inc. 49 Digna Biotech, S.L. 50 Elsalys Biotech SAS 51 F. Hoffmann-La Roche Ltd. 52 FibroGen, Inc. 53 Galapagos NV 54 Galectin Therapeutics, Inc. 55 GenKyoTex S.A. 56 GlaxoSmithKline Plc 57 Global Blood Therapeutics, Inc. 58
Purchase Complete Report @ http://www.reportsweb.com/buy&RW0001236047/buy/2000
About ReportsWeb:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us: Email: sales@reportsweb.com Call: +1-646-491-9876
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|
|
|
India RSS Feed Marketpalce
|
India News Headlines
Daily news from India: arts, business, culture, politics, science, technology & more.
Free Sales & Marketing Magazines
Get free publications about marketing, sales and customer relations management.
Submit RSS feed on India. Have your feed on news, products or services displayed under this marketpalce and have your feed on a full page updated daily.
|
|
India Business News by Major Cities
|
|
|
Listen to GroupWeb Radio
INDIA BUSINESS TV
|